Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2008

View Archived Issues

LY-450139 safe and well tolerated in Japanese subjects

Beneficial activity of CHF-5074 seen in mouse, guinea pig models of Alzheimer's disease

Imaging study reveals effects of GSK-189254 on cognition

Antitumor activity seen with PF-00299804 in several human xenograft models

NeuroPharma describes glycogen synthase kinase-3 inhibitor derived from marine organism

Meda and Valeant form joint ventures in Australia, Canada and Mexico

Celgene terminates satraplatin agreement with GPC Biotech

Mipomersen enters second phase III trial

Bayer acquires preclinical oncology program from Nycomed

Once-daily administration of RDEA-806 is safe and active against HIV in a phase II study

FDA grants orphan drug designation to SuperGen's MP-470 in glioblastoma multiforme

Cleveland receives notice of allowance from FDA to initiate phase I trial of Protectan CBLB-502

OrthoLogic reports positive results from preclinical study of Chrysalin in acute heart disease

Sonus signs exclusive in-licensing agreement with Bayer Healthcare for caspase activators

InNexus initiates primate study of DXL-625 antibody and adds DXLr-120 to pipeline

University of Texas Southwestern Medical Center initiates clinical trial of DOR's RiVax

Generex initiates enrollment in phase I clinical trial of AE-37 cancer vaccine

BioSante reacquires Elestrin from Nycomed

Oramed reports positive results from phase IIa clinical trial of ORMD-0801 in type 2 diabetes

Novel compounds for the treatment of cardiovascular disorders described in recent patents

HIV vaccine Vacc-4x enters phase IIb study

Patents disclose novel antiplatelet and anticoagulant compounds

Novel agents potentially useful for the treatment of cancer reported in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...